Scheduled Maintenance
We have scheduled some maintenance on Saturday 4th of May 2024 starting from 10AM CEST and could last for 2 hours. During this maintenance we are expecting our website to be unavailable or not fully functional.
NLS PHARMACEUTICS LTD (NLSP)
CH0523961370 - Common Stock
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.65M | 8.95M | 5.43M | 90.00K | 220.00K | |||
| Receivables | 64.28K | 40.00K | 40.00K | 60.00K | 50.00K | |||
| Other Current Assets | 529.46K | 260.00K | 250.00K | 40.00K | 110.00K | |||
| Total Current Assets | 2.25M | 9.25M | 5.72M | 200.00K | 380.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.40K | 20.00K | 30.00K | N/A | N/A | |||
| Other Non-Current Assets | 12.56K | 10.00K | 10.00K | 950.00K | 260.00K | |||
| Total Non-Current Assets | 24.96K | 30.00K | 40.00K | 1.01M | 320.00K | |||
| TOTAL ASSETS | 2.27M | 9.28M | 5.76M | 1.21M | 700.00K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 1.16M | 540.00K | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 610.00K | 150.00K | |||
| Accrued Expenses | 779.35K | 990.00K | 670.00K | 1.43M | 840.00K | |||
| Accounts Payable | 3.11M | 2.37M | 1.74M | 4.01M | 2.51M | |||
| Total Current Liabilities | 3.89M | 3.36M | 2.40M | 7.20M | 4.04M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 310.00K | 150.00K | |||
| Other Non-Current Liabilities | 2.66M | 2.64M | 2.82M | 2.68M | 2.68M | |||
| Total Non-Current Liabilities | 2.66M | 2.64M | 2.82M | 3.00M | 2.83M | |||
| TOTAL LIABILITIES | 6.56M | 6.00M | 5.22M | 10.20M | 6.87M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -65.81M | -58.20M | -41.71M | -29.76M | -26.90M | |||
| Additional Paid In Capital | 60.93M | 60.86M | 42.08M | 20.65M | 20.60M | |||
| Common Shares | 733.41K | 670.00K | 340.00K | 150.00K | 150.00K | |||
| Treasury Stock | -64.86K | 0.00 | -30.00K | N/A | N/A | |||
| Other Shareholders' Equity | -66.23K | -50.00K | -150.00K | -20.00K | -20.00K | |||
| Shares Outstanding | 32.43M | 32.43M | 16.22M | 11.78M | 11.78M | |||
| Tangible Book Value per Share | -0.13 | 0.10 | 0.03 | -0.76 | -0.52 | |||
| Total Shareholders' Equity | -4.29M | 3.28M | 540.00K | -8.98M | -6.17M | |||
| TOTAL LIABILITIES AND EQUITY | 2.27M | 9.28M | 5.76M | 1.21M | 700.00K | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | -0.16 | -0.11 | |||
| Current Ratio | 0.58 | 2.75 | 2.38 | 0.03 | 0.09 | |||
| Return On Assets (ROA) | -681.13% | -177.80% | -207.47% | -236.36% | -778.57% | |||
| Return On Equity (ROE) | N/A | -503.05% | -2212.96% | N/A | N/A | |||
All data in USD